Recent studies suggest that CD133 induces differentiation into non-hepatocyte-like lineages and may act as a progenitor cell marker not only in damaged liver and HCC tissue but also cholangiocarcinoma, both in vitro and in vivo [81,82]. Here, PROM1 is linked to hepatocellular carcinoma.